ArticleJAMA network open2021
Analysis of State Cannabis Laws and Dispensary Staff Recommendations to Adults Purchasing Medical Cannabis.
Article in JAMA network open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use.Substance use & addiction journal · 2026Article
- Medical Cannabis and Opioid Receipt Among Adults With Chronic Pain.JAMA internal medicine · 2026Article
- Cannabis Dispensary Staff ("Budtender") Perspectives on Trustworthiness of Social Media Information: A Qualitative Study.Cannabis (Albuquerque, N.M.) · 2026Article
- Cannabis Retailer Advice on Blunt, Tobacco, and Cannabis Use During Pregnancy.JAMA network open · 2025Article
- Medicinal and combined medicinal/recreational cannabis use in California following the passage of Proposition 64.Journal of cannabis research · 2025Article
- Association of Recreational Cannabis Legalization with Frequency of Using Cannabis for Sleep.Journal of psychoactive drugs · 2025Article
- Feasibility pilot of a novel coaching intervention to optimize cannabis use for chronic pain management among Veterans.Journal of cannabis research · 2025Article
- Budtender Perceptions and Knowledge of Cannabis and Mental Health: A Preliminary Study.Cannabis (Albuquerque, N.M.) · 2025Article
- Developing a Mock Retail Cannabis Shop for Research: A Description of The CANNEX.Cannabis (Albuquerque, N.M.) · 2025Article
- Cannabis-Derived Product Types, Flavors, and Compound Types From an E-Commerce Website.JAMA network open · 2024Article
- Physicians' Attitudes and Practices Regarding Cannabis and Recommending Medical Cannabis Use.Cannabis and cannabinoid research · 2024Article
- Dispensary personnel's views and experiences regarding oncologic cannabis and the counsel they offer adults with cancer.Cancer medicine · 2023Article
- Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey.BMC primary care · 2023Article
- Reasonable access: important characteristics and perceived quality of legal and illegal sources of cannabis for medical purposes in Canada.Journal of cannabis research · 2023Article
- The evolving culture of medical cannabis in Canada for the management of chronic pain.Frontiers in pharmacology · 2023Review
- Backgrounds and Trainings in Cannabis Therapeutics of Dispensary Personnel.JCO oncology practice · 2022Article
- Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain).Current rheumatology reports · 2022Review
- U.S. Trends in Registration for Medical Cannabis and Reasons for Use From 2016 to 2020 : An Observational Study.Annals of internal medicine · 2022Observational
- CBD Retailers in NC Promote CBD Online to Treat Pain Violating FDA Rules About Medical Claims and Offer Low-CBD/High-Price Products.Journal of pain research · 2022Article
Corrections and comments
- Commented on by
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Over the last decade, cannabis has become more accessible through the proliferation of dispensaries in states that have legalized its use. Most patients using cannabis for medical purposes report getting advice from dispensaries, yet there has been little exploration of frontline dispensary staff practices. Objective: To describe the practices of frontline dispensary workers who interact with customers purchasing cannabis for medical purposes and assess whether dispensary practices are associated with medicalization of state cannabis laws (degree to which they resemble regulation of prescription or over-the-counter drugs) and statewide adult use. Design, Setting, and Participants: This nationwide cross-sectional survey study was conducted from February 13, 2020, to October 2, 2020, using an online survey tool. Potential respondents were eligible if they reported working in a dispensary that sells tetrahydrocannabinol-containing products and interacting with customers about cannabis purchases. Main Outcomes and Measures: Participant responses to questions about formulating customer recommendations and talking to customers about risks. Results: The 434 survey responses from 351 unique dispensaries were most often completed by individuals who identified as budtenders (40%), managers (32%), and pharmacists (13%). Most respondents reported basing customer recommendations on the customer's medical condition (74%), the experiences of other customers (70%), the customer's prior experience with cannabis (67%), and the respondent's personal experience (63%); fewer respondents relied on clinician input (40%), cost (45%), or inventory (12%). Most respondents routinely advised customers about safe storage and common adverse effects, but few counseled customers about cannabis use disorder, withdrawal, motor vehicle collision risk, or psychotic reactions. A higher state medicalization score was significantly associated with using employer training (odds ratio, 1.41; 95% CI, 1.18-1.67) and physician or clinician input (odds ratio, 1.23; 95% CI, 1.05-1.43) as a basis for recommendation. Medicalization score was not associated with counseling about cannabis risks. Conclusions and Relevance: This survey study provides insight into how frontline dispensary staff base cannabis recommendations and counsel about risks. The findings may have utility for clinicians to counsel patients who purchase cannabis, customers who want to be prepared for a dispensary visit, and policy makers whose decisions affect cannabis laws.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.